Latest news

Image of the month - March

03 / 20 / 2023

Image of the month - March

Check out – It’s our Image of the BLUE March!
More than a color, more than a month…
🔵 Our everyday challenge, we are committed to our missions to fight cancer 🔵
Throughout March and beyond, we at Explicyte are calling for awareness of screening for colorectal and digestive cancers.

Image of the month - February

02 / 21 / 2023

Image of the month - February

Check out – It’s our favorite image of February!
What an incredible image we are sharing of a human TLS-positive lung biopsy!
Look carefully 🔎 to find an amazing phoenix perched as if rising from its fluorescent ashes. 🧐

 

Image of the month - January

01 / 16 / 2023

Image of the month - January

Check out – It’s our favorite image of January!
When science dives into pointillism…What a masterpiece!
Our fish in the ocean highlighting a Peyer’s patch on a human colon FFPE specimen is revealed using our multiplexed Tertiary Lymphoid Structure (TLS) detection panel.

Image of the month - December

12 / 16 / 2022

Image of the month - December

Check out - it’s our favorite image of December
O Christmas Tree! O Christmas Tree!
What a beautiful tonsil ‘fluorescently’ stained looking like an illuminated Christmas tree raised all in adornment! 🎄 The perfect match with the wonderful Christmas Season! ⛄
🎅 From all the Team, we wish you a Merry Christmas and Happy Holiday Season 🤶

How to fully exploit the mixed leukocyte reaction assay?

12 / 08 / 2022

How to fully exploit the mixed leukocyte reaction assay?

How to fully exploit the mixed leukocyte reaction assay?
for assessing
immunotherapeutics
on dendritic cell function and mediated immune response
While immunological synapse that occurs between T lymphocytes and dendritic cells (DCs) is a key component for an effective immune response, DC subpopulations are generated involving many signaling cues whose the nature only determines their functional properties

Image of the month - November

11 / 17 / 2022

Image of the month - November

Check out – It’s our ‘UNSHAVED’ image for Movember!
Beyond the mustache, we at Explicyte are calling for awareness to ‘change the face’ of men’s health - mental health issues and especially cancers.
Let’s dig together into and mobilize around male cancer research!

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced (.

10 / 21 / 2022

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced (.

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
Journal of Hemathology & Oncology, 2022 October 21

Maud Toulmonde, Sophie Cousin, Maud Toulmonde, Michèle Kind, Jean-Philippe Guegan, Alban Bessede, Coralie Cantarel, Carine Bellera and Antoine Italiano